Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
SARS-CoV Infection: full-pipeline trial registry
3 of 13 indexed SARS-CoV Infection trials are currently recruiting.
Corpus placement: #1,315 of 28,707 conditions by registered trial count.
13 US clinical trials · 3 currently recruiting · #1,315 of 28,707 conditions by registered trial count
SARS-CoV Infection: 13 US clinical trials tracked, 3 recruiting.
SARS-CoV Infection is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Veru, running 1 of these trials.
Enrollment posture brief
Registry condition sars-cov-infection
OPEN 3 | RECR 23% | LATE 4 | EARLY 4 | RANK #1315 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Endometrial Serous Adenocarcinoma (23% recruiting · 13 trials)
SARS-CoV Infection lists 3 open slots (23% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for SARS-CoV Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
SARS-CoV Infection is recruiting below its size-band peers.
3 of 13 indexed trials (23.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of SARS-CoV Infection trials is spread across many organizations.
Veru accounts for 1 of 13 trials (7.7%). 13 distinct sponsors appear on at least one study for this condition label.
-
Typical SARS-CoV Infection enrolment sits around 479 participants.
Median target enrolment is 479 among the 13 trials that report a genuine target (sentinel values excluded). 3 of those (23.1%) plan for fewer than 100 participants.
-
SARS-CoV Infection splits between interventional and observational designs.
9 interventional and 4 observational studies make up this index (69.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
13 total, page 1 of 1
KIDney Injury in Times of COVID-19 (KIDCOV)
University of California, San Francisco
NCT04705766
Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19
University of Texas Southwestern Medical Center
NCT05886816
Imaging Immune Activation in COVID-19
CellSight Technologies
NCT04815096
SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial
Milton S. Hershey Medical Center
NCT04802408
A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2
Novavax
NCT04611802
Michigan Medicine COVID-19 Cohort: Clinical Characteristics, Inflammatory Markers and Outcomes of Patients Hospitalized for COVID-19
University of Michigan
NCT04706533
COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)
University of Minnesota
NCT04510194
COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations
National Institute of Allergy and Infectious Diseases (NIAID)
NCT04761822
COVID-19 IgG Formation in Physicians at ALGH and Their Household Members
Wake Forest University Health Sciences
NCT04540484
Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease
Massachusetts General Hospital
NCT04332991
VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study
Veru
NCT04842747
Self-Collected Saliva Samples Without Viral Transport Media for COVID-19 Testing Via RT-PCR
David Grant U.S. Air Force Medical Center
NCT04604145
Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19
George Washington University
NCT05063812
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 4 |
| Phase 3 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on SARS-CoV Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on SARS-CoV Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this SARS-CoV Infection page
13 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 SARS-CoV Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Veru sponsors the most SARS-CoV Infection trials on record, review their full trial history before evaluating a specific study. See Veru's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This SARS-CoV Infection condition card totals 13 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.